As we age we can have the independent lifestyle we desire


Happy New Year

OrgaNext Research wishes you a happy, healthy and successful 2018

OrgaNext CEO in 2017 outlook special Life Science Leader Magazine

Crowdfunding Success OrgaNext

Crowdfunding Success OrgaNext in the Netherlands      

OrgaNext’s new approach to Recovery from Hip Fracture on NPR’s BioTechNation


OrgaNext ‘Company to Watch’ by Life Science Leader’ Magazine in USA

OrgaNext Research is ‘Company to Watch’ in the December 2014 issue of ‘Life Science Leader Magazine’. Wayne Koberstein, Executive Editor puts the spotlight on OrgaNext, highlighting the company’s novel Recovery Booster therapy for older patients. He underlines the critical unmet need with a personal story, before concluding “Many, like me, know what could be at stake in […]

OrgaNext CEO on US National Public Radio

Marjanne Prins, Founder and CEO of OrgaNext Research was recently interviewed by award winning science journalist Moira Gunn, host of Tech Nation and its regular segment BioTech Nation, a weekly interview program talk show that airs four times each weekend on America’s National Public Radio (NPR). BioTech Nation presents interviews with leading biotech scientists, CEOs, […]

Promising clinical results of OrgaNext’ Recovery Booster therapy

Arnhem, The Netherlands – June 30, 2014 – OrgaNext Research, a Dutch biopharmaceutical company, announced the results of the first clinical studies in older people with its novel Recovery Booster therapy. The studies showed that the innovative therapy is safe and well tolerated by older women (65-79 years) and that biomarker data are indicative of […]

22 million women over 50 are affected by osteoporosis in EU

A recent report issued by the International Osteoporosis Foundation (IOF) estimates that more than 22 million women aged between 50–84 years in the European Union (EU) have osteoporosis1.  Postmenopausal women are at greatest risk of broken bones due to the hormonal changes that occur at menopause which result in rapid loss of bone mass2. Osteoporosis […]

European Patent granted to OrgaNext Research

  Arnhem, the Netherlands, May 15, 2013 – OrgaNext Research BV announced today that a European Patent has been granted for its Recovery Booster therapy in frail elderly patients.   “We are very pleased to receive the European Patent for our lead Recovery Booster therapy, as it recognizes the novelty and innovative character of our approach […]

Spotlight on OrgaNext treatment to regenerate elderly muscle

MedNous, the independent publication for Life Science insiders, puts the spotlight on OrgaNext’s regenerative medicine. In the April 2013 edition it features the story of the Dutch development of a regenerative treatment for elderly patients.   Learn more: MedNous on OrgaNext April 2013

OrgaNext at BNR Radio